Clinical Overview
The Centor Score (and its age-adjusted modification, the McIsaac Score) is a highly validated clinical decision tool used in outpatient and emergency settings to estimate the probability that a patient presenting with a sore throat has Group A Streptococcal (GAS) pharyngitis. Because most cases of pharyngitis are viral, this tool is essential for antibiotic stewardship—preventing the unnecessary prescription of antibiotics for viral infections while ensuring those at high risk for acute rheumatic fever or peritonsillar abscess receive appropriate treatment.
Pathophysiology & Evidence
Streptococcal pharyngitis presents with classic signs that differentiate it from viral upper respiratory infections. Viral infections typically present with coryza, conjunctivitis, and a prominent cough. In contrast, GAS pharyngitis often presents with a sudden onset of fever, painful swallowing, tonsillar exudates, and tender anterior cervical lymphadenopathy.
The Centor criteria rely on these distinguishing features. The absence of a cough is a critical predictor because a cough strongly points toward a viral etiology (such as rhinovirus or adenovirus).
Formula Breakdown
The calculator utilizes a point-based system:
Score &= Fever(1) \ &\quad + Exudates(1) \ &\quad + Cervical Nodes(1) \ &\quad + Absence of Cough(1) \ &\quad + Age Modifier
Patients scoring 0-1 have a very low probability of strep and require no testing or treatment. Patients scoring 2-3 should undergo rapid antigen detection testing (RADT). Patients scoring 4-5 have a >50% probability of strep and may be considered for empiric antibiotic therapy, though many guidelines still recommend RADT confirmation.